Altered innate defenses in the neonatal gastrointestinal tract in response to colonization by neuropathogenic escherichia coli

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3264-3275

  Birchenough, George M H ^a,b   Johansson, Malin E V ^b   Stabler, Richard A ^c   Dalgakiran, Fatma ^a   Hansson, Gunnar C ^b   Wren, Brendan W ^c   Luzio, J Paul ^d   Taylor, Peter W ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; MUCIN 2; TREFOIL FACTOR TFF2; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; INNATE IMMUNITY; MICROFLORA; NEUROPATHOGENIC ESCHERICHIA COLI; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

EID: 84884224015     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00268-13     Document Type: Article

References (75)

1. Harvey D, Holt DE, Bedford H. 1999. Bacterial meningitis in the newborn: a prospective study of mortality and morbidity. Semin. Perinatol. 23:218-225.
2. Brouwer MC, Tunkel AR, van de Beek D. 2010. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin. Microbiol. Rev. 23:467-492.
3. Robbins JB, McCracken GH, Gotschlich EC, Ørskov F, Ørskov I, Hanson LA. 1974. Escherichia coli K1 polysaccharide associated with neonatal meningitis. N. Engl. J. Med. 290:1216-1220.
4. Korhonen TK, Valtonen MV, Parkkinen J, Väisänen-Rhen V, Finne J, Ørskov F, Ørskov I, Svenson SB, Mäkelä PH. 1985. Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect. Immun. 48:486-491.
5. Rutishauser U. 2008. Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat. Rev. Neurosci. 9:26-35.
6. Levy O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7:379-390.
7. de Louvois J. 1994. Acute bacterial meningitis in the newborn. J. Antimicrob. Chemother. 34(Suppl A):61-73.
8. SarffLD, McCracken GH, Schiffer MS, Glode MP, Robbins JB Ørskov I, Ørskov F. 1975. Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet i:1099-1104.
9. Schiffer MS, Oliveira E, Glode MP, McCracken G, SarffLM, Robbins JB. 1976. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr. Res. 10:82-87.
10. Obata-Yasuoka M, Ba-Thein W, Tsukamoto T, Yoshikawa H, Hayashi H. 2002. Vaginal Escherichia coli share common virulence factor profile, serotypes and phylogeny with other extraintestinal E. coli. Microbiology 148:2745-2752.
11. Palmer C, Bik EM, DiGuilio DB, Relman DA, Brown PO. 2007. Development of the human infant intestinal microbiota. PLoS Biol. 5:1556-1573.
12. Nassif X, Bourdoulous S, Eugène E, Couraud P-E. 2002. How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol. 10:227-232.
13. Tunkel AR, Scheld WM. 1993. Pathogenesis and pathophysiology of bacterial meningitis. Clin. Microbiol. Rev. 6:118-136.
14. Glode MP, Sutton A, Moxon ER, Robbins JB. 1977. Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect. Immun. 16:75-80.
15. Pluschke G, Mercer A, Kusećek B, Pohl A, Achtman M. 1983. Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certainO(lipopolysaccharide) antigen types. Infect. Immun. 39:599-608.
16. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob. Agents Chemother. 48:1503-1508.
17. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2005. Treatment of experimental Escherichia coli infection with recombinant bacteriophagederived capsule depolymerase. J. Antimicrob. Chemother. 56:160-165.
18. Martindale J, Stroud D, Moxon ER, Tang CM. 2000. Genetic analysis of Escherichia coli K1 gastrointestinal colonization. Mol. Microbiol. 37:1293-1305.
19. Zelmer A, Bowen M, Jokilammi A, Finne J, Luzio JP, Taylor PW. 2008. Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1. Microbiology 154:2522-2532.
20. Zelmer A, Martin MJ, Gundogdu O, Birchenough G, Lever R, Wren BW, Luzio JP, Taylor PW. 2010. Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1. Microbiology 156:2205-2215.
21. Pluschke G, Pelkonen S. 1988. Host factors in the resistance of newborn mice to K1 Escherichia coli infection. Microb. Pathog. 4:93-102.
22. Polin RA, Harris MC. 2001. Neonatal bacterial meningitis. Semin. Neonatol. 6:157-172.
23. Jennings HJ, Brisson J-R, Kulakowska M, Michon F. 1993. Polysialic acid vaccines against meningitis caused by Neisseria meningitidis B and Escherichia coli K1, p 25-38. In Roth J, Rutishauser U, Troy FA (ed), Polysialic acid. Birkhäuser Verlag, Basel, Switzerland.
24. Lee A, Gordon J, Lee C-J, Dubos R. 1971. The mouse intestinal microflora with emphasis on the strict anaerobes. J. Exp. Med. 133:339-352.
25. Achtman M, Mercer A, Kusećek B, Pohl A, Heuzenroeder M, Aaronson W, Sutton A, Silver RP. 1983. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect. Immun. 39:315-335.
26. Gross RJ, Cheasty T, Rowe B. 1977. Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli. J. Clin. Microbiol. 6:548-550.
27. Palmer C, Bik EM, Eisen MB, Echberg PB, Sana TR, Wolber PK, Relman DA, Brown PO. 2006. Rapid quantitative profiling of complex microbial populations. Nucleic Acids Res. 34:e5. doi:10.1093/nar/gnj007.
28. Steenbergen SM, Vimr ER. 2008. Biosynthesis of the Escherichia coli K1 group 2 polysialic acid capsule occurs within a protected cytoplasmic compartment. Mol. Microbiol. 68:1252-1267.
29. Cummins AG, Jones BJ, Thompson FM. 2006. Postnatal epithelial growth of the small intestine in the rat occurs by both crypt fission and crypt hyperplasia. Dig. Dis. Sci. 51:718-723.
30. Hansson J, Panchaud A, Favre L, Bosco N, Mansourian R, Benyacoub J, Blum S, Jensen ON, Kussmann M. 2011. Time-resolved quantitative proteome analysis of in vivo intestinal development. Mol. Cell Proteom. 10:M110.005231. doi:10.1074/mcp. M110.005231.
31. Pácha J. 2000. Development of intestinal transport function in mammals. Physiol. Rev. 80:1633-1667.
32. Udall JM, Pang K, Fritze L, Kleinman R, Walker WA. 1981. Development of gastrointestinal mucosal barrier. I. The effect of age on intestinal permeability to macromolecules. Pediatr. Res. 15:241-244.
33. Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL. 1987. Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect. Immun. 55:2689-2694.
34. Andersson AF, Lindberg M, Jakobsson H, Bäckhed F, Nyrén P, Engstrand L. 2008. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 3:e2836. doi:10.1371/journal.pone.0002836.
35. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI. 2008. Evolution of mammals and their gut microbes. Science 320:1647-1651.
36. Ludwig W, Bauer SH, Bauer M, Held I, Kirchhof G, Schulze R, Haber I, Spring S, Hartmann A, Schleifer KH. 1997. Detection and in situ identification of representatives of a widely distributed new bacterial phylum. FEMS Microbiol. Lett. 153:181-190.
37. Quaiser A, Ochsenreiter T, Lanz C, Schuster SC, Treusch AH, Eck J, Schleper C. 2003. Acidobacteria form a coherent but highly diverse group within the bacterial domain: evidence from environmental genomics. Mol. Microbiol. 50:563-575.
38. Barns SM, Cain EC, Sommerville L, Kuske CR. 2007. Acidobacteria phylum sequences in uranium-contaminated subsurface sediments greatly expand the known diversity within the phylum. Appl. Environ. Microbiol. 73:3113-3116.
39. Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI. 2008. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol. 6:776-788.
40. Stearns JC, Lynch MDJ, Senadheera DB, Tenenbaum HC, Goldberg MB, Cvitkovitch DG, Croitoru K, Moreno-Hagelsieb G, Neufeld JD. 2011. Bacterial biogeography of the human digestive tract. Sci. Rep. 1:170. doi:10.1038/srep00170.
41. Spieck E, Bock E. 2005. The lithoautotrophic nitrogen-oxidizing bacteria, p 149-153. In Garrity G (ed), Bergey's manual of systematic bacteriology, 2nd ed, vol 2. Springer, Berlin, Germany.
42. Soulat D, Bürckstümmer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. 2008. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27:2135-2146.
43. Karlsson J, Pütsep K, Chu H, Kays RJ, Bevins CL, Andersson M. 2008. Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. BMC Immunol. 9:37. doi:10.1186/1471-2172-9-37.
44. Bevins CL, Salzman NH. 2011. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 9:356-368.
45. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjöberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, Bos NA. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11:76-83.
46. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. 2008. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. U. S. A. 105:20858-20863.
47. Sherman MP, Bennett SH, Hwang FFY, Sherman J, Bevins CL. 2005. Paneth cells and antibacterial host defense in neonatal small intestine. Infect. Immun. 73:6143-6146.
48. Johansson MEV, Hansson GC. 2011. Keeping bacteria at a distance. Science 334:182-183.
49. Kjellev S. 2009. The trefoil factor family-small peptides with multiple functionalities. Cell. Mol. Life Sci. 66:1350-1369.
50. Shub MD, Pang KY, Swann DA, Walker WA. 1983. Age-related changes in chemical composition and physical properties of mucus glycoproteins from rat small intestine. Biochem. J. 215:405-411.
51. Dossinger V, Kayademir T, Blin N, Gött P. 2002. Down-regulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factors. Cell Physiol. Biochem. 12:197-206.
52. Oeckinghaus A, Hayden MS, Ghosh S. 2011. Crosstalk in NF-κB signalling pathways. Nat. Immunol. 12:695-708.
53. Van der Waaij D, Burghuis JM, Lekkerkerk JE. 1972. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J. Hyg. (Lond.) 70:605-610.
54. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543-547.
55. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone CA, Knight R, Duncan AE, Bain JR, Muehlbauer MJ, Newgard CB, Heath AC, Gordon JI. 2011. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 3:106ra106. doi:10.1126/scitranslmed.3002701.
56. Coconnier MH, Lievin V, Lorrot M, Servin AL. 2000. Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells. Appl. Environ. Microbiol. 66:1152-1157.
57. Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA. 2004. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med. Microbiol. 40:223-229.
58. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638.
59. Hayashi H, Takahashi R, Nishi T, Sakamoto M, Benno Y. 2005. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J. Med. Microbiol. 54:1093-1101.
60. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. 2006. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. U. S. A. 103:732-737.
61. Chambers JA, Hollingsworth MA, Trezise AE, Harris A. 1994. Developmental expression of mucin genes MUC1 and MUC2. J. Cell Sci. 107:413-424.
62. Fança-Berthon P, Michel C, Pagniez A, Rival M, Van Seuningen I, Darmaun D, Hoebler C. 2009. Intrauterine growth restriction alters postnatal colonic barrier maturation in rats. Pediatr. Res. 66:47-52.
63. Bry L, Falk P, Huttner K, Ouellette A, Midtvedt T, Gordon JI. 1994. Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 91:10335-10339.
64. Mallow EB, Harris A, Salzman N, Russell JP, DeBerardinis RJ, Ruchelli E, Bevins CL. 1996. Human enteric defensins. Gene structure and developmental expression. J. Biol. Chem. 271:4038-4045.
65. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. U. S. A. 105:15064-15069.
66. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV. 2011. The antibacterial lectin RegIIIγ promotes the spatial segregation of microbiota and host in the intestine. Science 334:255-258.
67. Kim YS, Ho SB. 2010. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr. Gastroenterol. Rep. 12:319-330.
68. Lin J, Holzman IR, Jiang P, Babyatsky MW. 1999. Expression of intestinal trefoil factor in developing rat intestine. Biol. Neonate 76:92-97.
69. Yu H, He Y, Zhang X, Peng Z, Yang Y, Zhu R, Bai J, Tian Y, Li X, Chen W, Fang D, Wang R. 2011. The rat IgGFcγBP and Muc2 C-terminal domains and TFF3 in two intestinal mucus layers bind together by covalent interaction. PLoS One 6:e20334. doi:10.1371/journal.pone.0020334.
70. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. 2005. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115:66-75.
71. Lotz M, Gütle D, Walther S, Ménard S, Bogdan C, Hornef MW. 2006. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203:973-984.
72. Maheshwari A, Kelly DR, Nicola T, Ambalavanan N, Jain SK, Murphy-Ullrich J, Athar M, Shimamura M, Bhandari V, Aprahamian C, Dimmitt RA, Serra R, Ohls RK. 2011. TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140:242-253.
73. Shi J, Aono S, Lu W, Ouellette AJ, Hu X, Ji Y, Wang L, Lenz S, van Ginkel FW, Liles M, Dykstra C, Morrison EE, Elson CO. 2007. A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J. Immunol. 179:1245-1253.
74. Lindén SK, Florin TH, McGuckin MA. 2008. Mucin dynamics in intestinal bacterial infection. PLoS One 3:e3952. doi:10.1371/journal.pone.0003952.
75. Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, Ryz N, Huang T, Velcich A, Finlay BB, Chadee K, Vallance BA. 2010. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6:e1000902. doi:10.1371/journal.ppat.1000902.